Global Orthobiologics Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Orthobiologics Market was valued at $7.4 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.1% CAGR, to an estimated market size of $9.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global orthobiologics market comprises biologically active substances and regenerative therapies used to repair, replace, or regenerate musculoskeletal tissues such as bone, cartilage, tendons, and ligaments. The scope includes bone grafts, viscosupplementation, stem cell therapies, and platelet-rich plasma (PRP), while excluding standard metallic fixation hardware and non-biologic joint prosthetics.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Orthobiologics Market in the period 2025-30:
- The rising global geriatric population is significantly increasing the prevalence of osteoarthritis and degenerative spinal conditions.
- There is a rapid shift toward minimally invasive surgery (MIS), driving demand for injectable and moldable biologic formulations.
- Increasing adoption of regenerative medicine techniques like PRP and mesenchymal stem cells is offering alternatives to traditional surgical hardware.
- The integration of artificial intelligence (AI) and 3D printing is enhancing the development of personalized bone scaffolds and recovery monitoring.
- A notable transition of procedures from hospitals to Ambulatory Surgical Centers (ASCs) is fueling the demand for cost-effective, outpatient-based biologic solutions.
- Clinical preference is shifting toward off-the-shelf bone graft substitutes to reduce patient morbidity associated with autograft harvesting.
- Stricter regulatory requirements and the need for high-quality clinical evidence are becoming critical barriers for new product market entry.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Viscosupplementation
- Bone Grafts & Substitutes
- Cell-based Therapies